Skip to main content
56kviews
Editorial21 June 2022
Editorial: Immune Aging: Implications for Transplantation

doubling the rate of telomere erosion. Similarly, age impacts DNA methylation patterns, which are reset during embryogenesis and undergo characteristic changes over time. Dugger et al. observed that lung epithelial cells, also derived by small airway brushing, have a pattern of epigenetic age determined by the donor birthdate (2). These lung allografts all came from nonsmoking donors, but epigenetic age was greater in allografts that had experienced primary graft dysfunction, again suggesting that stressors can accelerate biological aging. Both of these studies were underpowered to show an association with chronic lung allograft dysfunction or survival, but nominal hazard ratios suggested that donor biologic age was associated with worse outcomes, as has been seen in other studies (3)(4)(5). As Lin et al. summarize, allograft age is associated with stem cell dysfunction, senescence, mitochondrial dysfunction, and chromosomal alterations that can drive functional decline in stem cell and solid organ allografts (6).

Older transplant recipients experience increased incidence of infection, malignancy, and death compared with younger patients, likely as a result of immune senescence associated with aging (7). Epigenetics and telomere dysfunction also contribute to the biological age of the recipient's immune system (8,9), and there are additional immune-specific aging mechanisms. CMV is a particularly strong driver of accelerate immune age. Higdon et al. demonstrated an increase in phenotypically aged CD8+ T cells, as defined by telomere length, CD57 expression, and terminal differentiation, in CMV seropositive patients (10). Innate T cells can also demonstrate immune senescence. Daniel et al. used KIR, NKG2A, and Eomesodermin to define a subtype of senescent innate T cells, which also had features resembling senescent adaptive T cells (CD27-/CD28-) and were more common in CMV seropositive kidney transplant recipients, independent of chronologic age (11). Chronic kidney disease can also accelerate immune aging, as evidenced by increased terminal differentiation in both responder and regulatory T cells in pre-and post-kidney transplant recipients (12).Immune aging may affect responses to pathogens or the allograft. Donor-specific hyporesponsiveness has been seen in older patients and may explain decreased risk for rejection.Van der List et al. observed an association between T cell immunoglobulin and ITIM domain (TIGIT), a marker of exhaustion, and polyfunctional donor-reactive CD4+ T cells in a cohort of younger and older kidney transplant recipients (13).The ability to target and reverse immune senescence holds promise for the older patient with cancer or requiring hematopoietic cell transplantation (HCT). Lin et al. reviewed the impact of immune senescence on HCT recipients and opportunities for reversing senescence including dasatinib plus quercertin, anakinra, or mTOR inhibitors.

While allograft age is retained after transplantation, allograft and recipient age do not remain entirely separate. Tissue-specific stem cells can migrate from recipient to allograft and vice versa (14) leading to age chimerism. As Iske et al. describe, donor-derived senescent cells can also induce aging phenotypes in the recipient through the section of cytokines, chemokines, and matrix remodeling enzymes or through direct cell contact (15). Even a small number of transplanted senescent cells can induce senescence in multiple organs throughout the recipient in experimental models. Youthful allografts could theoretically drive rejuvenation, but the data here are less clear.

Observations in transplantation demonstrate help us understand the biological basis of aging phenotypes and the extent to which they can be manipulated, with important implications for aging biology more generally. In the care of a transplant candidate or recipient, understanding the mechanisms behind immune senescence may facilitate the optimal selection and matching of organs and candidates to optimize outcomes, and suggest interventions to ameliorate vulnerability to infection without increasing rejection risk. Mounting evidence that biologic age can differ from chronologic age indicates that measuring biologic age in the allograft and through immunologic assessment in transplant candidates and recipients may provide actionable clinical data.Funding: JRG is supported by Veteran Affairs Office of Research and Development, CSR&D section (CX002011), the National Heart Lung and Blood Institute (HL151552), and the Cystic Fibrosis Foundation. SGT has been supported by grants from the NIH (R56AGO39449, R01AG064165 and U01AI132898). JS is supported by the National Institute of Aging (R21 AG055879-01A1) and the Mendez Transplant Institute.

2,025 views

1 citations

Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction
ORIGINAL RESEARCH
7 October 2021
Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction
Daniel T. Dugger, 13 more and John R. Greenland

3,815 views

23 citations

Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant
Immune function is altered with increasing age. Infection with cytomegalovirus (CMV) accelerates age-related immunological changes resulting in expanded oligoclonal memory CD8 T cell populations with impaired proliferation, signaling, and cytokine production. As a consequence, elderly CMV seropositive (CMV+) individuals have increased mortality and impaired responses to other infections in comparison to seronegative (CMV–) individuals of the same age. CMV is also a significant complication after organ transplantation, and recent studies have shown that CMV-associated expansion of memory T cells is accelerated after transplantation. Thus, we investigated whether immune aging is accelerated post-transplant, using a combination of telomere length, flow cytometry phenotyping, and single cell RNA sequencing. Telomere length decreased slightly in the first year after transplantation in a subset of both CMV+ and CMV– recipients with a strong concordance between CD57+ cells and short telomeres. Phenotypically aged cells increased post-transplant specifically in CMV+ recipients, and clonally expanded T cells were enriched for terminally differentiated cells post-transplant. Overall, these findings demonstrate a pattern of accelerated aging of the CD8 T cell compartment in CMV+ transplant recipients.

6,353 views

28 citations

ORIGINAL RESEARCH
21 July 2021
Allotransplantation Is Associated With Exacerbation of CD8 T-Cell Senescence: The Particular Place of the Innate CD8 T-Cell Component
Lauren Daniel, 5 more and Alice Barbarin

4,516 views

18 citations

Development of T-cell hyporesponsiveness to donor antigen may explain the substantial decreased risk for acute rejection in the years following kidney transplantation. The underlying mechanisms of donor-specific hyporesponsiveness (DSH) are largely unknown but may allow for lowering of immunosuppressive medication. Due to the onset of DSH being more rapid and pronounced in older recipients (+55 years), we hypothesized that immunosenescence/exhaustion of T lymphocytes would be a contributing factor. This study tested whether donor-specific recipient T cells become hyporesponsive due to exhaustion from continuous stimulation by donor antigen. Circulating donor-specific T cells of both young and elderly stable kidney transplant recipients (N=17) before and 3-5 years after transplantation were analyzed at the single cell level for expression of exhaustion markers by multi-parameter flow cytometry followed by unsupervised and unbiased clustering. Clusters containing cells of a particular expression profile with significant differential abundance after transplantation were identified and further analyzed. Unexpectedly, our results do not demonstrate an increase in exhausted donor antigen-specific T cells post transplantation. Instead, we demonstrate a significant decrease in donor antigen-specific CD4+ T cells expressing T cell immunoglobulin and ITIM domain (TIGIT) long after transplantation. Further analysis at earlier timepoints indicated that this decrease is already present at six months post transplantation. Characterization of these CD4+ T donor-specific cells expressing TIGIT revealed them to have a predominantly central and effector memory T cell phenotype and a highly poly-functional cytokine expression profile. This study has therefore identified TIGIT as a marker for a previously undescribed polyfunctional donor-specific CD4+ T cell population whose decline following kidney transplantation may explain development of DSH.

4,618 views

28 citations

In transplantation, donor and recipients frequently differ in age. Senescent cells accumulate in donor organs with aging and have the potential to promote senescence in adjacent cells when transferred into recipient animals. Characteristically, senescent cells secrete a myriad of pro-inflammatory, soluble molecules as part of their distinct secretory phenotype that have been shown to drive senescence and age-related co-morbidities. Preliminary own data show that the transplantation of old organs limits the physical reserve of recipient animals. Here, we review how organ age may affect transplant recipients and discuss the potential of accelerated aging.

7,310 views

22 citations

Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation
MINI REVIEW
19 April 2021
Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation
Richard J. Lin, 1 more and Marcel R. M. van den Brink

6,481 views

27 citations

ORIGINAL RESEARCH
16 April 2021
Airway Telomere Length in Lung Transplant Recipients
John A. Mackintosh, 4 more and Daniel C. Chambers

2,675 views

6 citations